Ocrevus
Ocrevus is a medicine containing Ocrelizumab, listed in the Romanian national register of medicines for human use with 2 presentations.
General information from the official register, not medical advice. Anpheros does not diagnose and does not recommend medicines. Read the package leaflet and ask your doctor or pharmacist before taking any medicine.
At a glance
- Active substance
- OCRELIZUMABUM
- ATC code
- L04AG08 Antineoplastic and immunomodulating agents
- Therapeutic action
- IMUNOSUPRESOARE ANTICORPI MONOCLONALI
IMUNOSUPRESOARE - Prescription
- Prescription required (register code PR)
- Marketing authorisation holder
- ROCHE REGISTRATION GMBH - GERMANIA
- Manufacturer
- ROCHE PHARMA AG - GERMANIA
- Pharmaceutical form
- CONC. PT. SOL. PERF.
SOL. INJ.
Presentations and codes
CIM is the code of each pack in the Romanian register; the Anpheros app saves it when it recognises the box.
| CIM code | Form | Strength | Pack | Prescription | Authorisation | Shelf life |
|---|---|---|---|---|---|---|
| W64485001 | CONC. PT. SOL. PERF. | 30mg/ml | Cutie cu 1 flac. x 10 ml concentrat pentru solutie perfuzabila | PR | 1231/2018/01 | 18 luni |
| W70385001 | SOL. INJ. | 40mg/ml | Cutie cu 1 flac. x 23 ml sol. inj. | PR | 1231/2018/03 | 2 ani |
What it is used for
The official indications for Ocrelizumab, quoted from the European Medicines Agency and the US FDA, are on Ocrelizumab in Anpheros Search.
The package leaflet and the summary of product characteristics are published by ANMDMR: search for “Ocrevus” in the national register.
Scan the box in Anpheros
In the Anpheros Daily app, photograph the medicine box: the app reads the name and strength, matches them against this register and adds the medicine to your list, with its code. From your list you can come back to this page.
Source: ANMDMR — National Agency for Medicines and Medical Devices of Romania, Nomenclatorul medicamentelor de uz uman (register updated 29 October 2026). Shown as published, in Romanian where the register is in Romanian.